NCT06036407 2026-04-14
HEAR
University of Bern
Phase NA Completed
Clinical Trials
12 trialsNCT06553157 2026-01-20
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Minia University
Phase 1/2 Completed
NCT05789316 2026-01-12
Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)
Washington University School of Medicine
Phase NA Completed
NCT02425397 2025-12-01
OTOPLAT
Assistance Publique - Hôpitaux de Paris
Completed
NCT00716976 2023-11-09
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
Children's Oncology Group
Phase 3 Completed
NCT04262336 2023-07-06
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Decibel Therapeutics
Phase 1 Completed
NCT02890030 2020-04-08
The Platinum Study Comparison Group
Indiana University
Completed
NCT01848457 2020-03-16
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Children's Hospital of Philadelphia
Phase 2 Completed
NCT00652132 2018-05-29
SIOPEL6
University of Birmingham
Phase 3 Completed
NCT03400709 2018-01-17
Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer
Hospital San Juan de Dios, Santiago
Phase NA Completed
NCT00458887 2017-03-13
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Children's Oncology Group
Completed
NCT00477607 2014-03-07
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
VA Office of Research and Development
Phase 2/3 Completed